CDK5 was reported to be involved in the regulation of proliferation and survival of breast cancer cells, and CDK5 was characterized as a downstream target of extracellular regulated protein kinases in carboplatin-induced cell death [27, 28]. This evidence concerns the gene CDK5 and breast cancer.